Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 8,717,557
- Share change
- -61,248
- Total reported value
- $21,792,392
- Price per share
- $2.50
- Number of holders
- 20
- Value change
- -$155,396
- Number of buys
- 6
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
27%
|
7,564,934
|
$19,291,000 | — | 30 Jun 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
395,160
|
$1,007,000 | — | 30 Jun 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
300,000
|
$765,000 | — | 30 Jun 2018 | |
| Artal Group S.A. |
13F
|
Company |
0.53%
|
150,000
|
$383,000 | — | 30 Jun 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.43%
|
123,812
|
$316,000 | — | 30 Jun 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.23%
|
66,146
|
$169,000 | — | 30 Jun 2018 | |
| ELEMENT CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
58,517
|
$149,000 | — | 30 Jun 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
18,466
|
$47,000 | — | 30 Jun 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
15,544
|
$39,000 | — | 30 Jun 2018 | |
| WILLIAMS JONES & ASSOCIATES LLC |
13F
|
Company |
0.05%
|
15,272
|
$39,000 | — | 30 Jun 2018 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.04%
|
12,607
|
$32,000 | — | 30 Jun 2018 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.04%
|
12,042
|
$31,000 | — | 30 Jun 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
10,683
|
$28,000 | — | 30 Jun 2018 | |
| Paloma Partners Management Co |
13F
|
Company |
0.04%
|
10,780
|
$27,000 | — | 30 Jun 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
10,060
|
$26,000 | — | 30 Jun 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
5,339
|
$14,000 | — | 30 Jun 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
3,171
|
$8,000 | — | 30 Jun 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
3,033
|
$7,000 | — | 30 Jun 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,348
|
$3,000 | — | 30 Jun 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,221
|
$3,000 | — | 30 Jun 2018 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$2,000 | — | 30 Jun 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Jun 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
371
|
$1,000 | — | 30 Jun 2018 | |
| CWM, LLC |
13F
|
Company |
0%
|
310
|
$1,000 | — | 30 Jun 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
301
|
$1,000 | — | 30 Jun 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
157
|
$400 | — | 30 Jun 2018 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q3 2018
As of 30 Sep 2018,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,717,557 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, Artal Group S.A., BlackRock Inc., ELEMENT CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Destination Wealth Management, MORGAN STANLEY, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
24
Q3 2018 holders
20
Holder diff
-4
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.